image
Kymera Therapeutics, Inc. KYMR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 30.17
-4.17 %
$ 1.96 B
Market Cap
-9.69
P/E
Price Target Average
86.03%
Revenue Forecast Estimate
87.11%
EBIT Estimate
--21.86%
Net Income Estimate
25.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Kymera Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for KYMR of $56.1 , with forecasts ranging from a low of $46 to a high of $65 .
KYMR Lowest Price Target Wall Street Target
46 USD 52.47%
KYMR Average Price Target Wall Street Target
56.1 USD 86.03%
KYMR Highest Price Target Wall Street Target
65 USD 115.45%
Price
Max Price Target
Min Price Target
Average Price Target
6565606055555050454540403535303025252020Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart KYMR

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart KYMR

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart KYMR

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029